Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Protea Biosciences Group, Inc. | v432195_10k.htm |
| EX-31.1 - EXHIBIT 31.1 - Protea Biosciences Group, Inc. | v432195_ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - Protea Biosciences Group, Inc. | v432195_ex21-1.htm |
| EX-10.96 - EXHIBIT 10.96 - Protea Biosciences Group, Inc. | v432195_ex10-96.htm |
Exhibit 32.1
CERTIFICATION
In connection with the Annual Report of Protea Biosciences Group, Inc. (the “Company”) on Form 10-K for the year ending December 31, 2015 as filed with the Securities and Exchange Commission (the “Report”), I, Stephen Turner, Chief Executive Officer (Principal Executive Officer and Interim Principal Financial and Accounting Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of our knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. |
| Date: March 16, 2016 | ||
| /s/ Stephen Turner | ||
| Stephen Turner | ||
Chief Executive Officer, President and Director (Principal Executive Officer, Interim Principal Financial and Accounting Officer) |